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Background
• Although it is more common to initiate medicationassisted treatment (MAT) for opioid use disorder
(OUD), there are approved medications for the
management of alcohol use disorder (AUD) as well, such
as naltrexone. However, this is not currently a
common medication prescribed in the inpatient setting
prior to discharge.
• Often, patients are discharged on gabapentin, but not at
doses that have been studied to reduce cravings (9001800 mg/day)[1].
• Project AIM: increase the prescribing of this medication
as an inpatient to ideally provide more support to
patients with alcohol use disorder.
Baseline Metrics and Methods
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39/42 have not prescribed naltrexone, but 38/42 would definitely, if
they had more resources
Concurrent opioid use
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Didn’t know enough about
the med to prescribe it

33

Don’t know about
contraindications or how to
counsel

26

Worry the patient won’t
have follow up
I prefer gabapentin

[2].
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It didn’t occur to me
6

60 inpatient orders
for naltrexone

Challenges and Lessons Learned
• Lack of awareness
• Some are skeptical of naltrexone effectiveness (lack of
faculty response to survey for baseline data)
• Need to engage key stakeholders
• Culture change?
• Too many patients with contraindications?

• However, there are more admissions for AUD
(5,532 vs. 4,076)

Future Directions

• Current TJUH alcohol withdrawal guidelines suggest
discharge on gabapentin 300mg BID to reduce
cravings

• Automate the process?
• Order sets?

• RedCap survey was sent to residents, pharmacy,
gastroenterology, hepatology, primary care and
hospitalists to get baseline perception data

• Education sessions?
• Discuss other institution practices?

Benefits of Naltrexone
Once a day dosing, affordable, minimal side effects. No
street value (vs. Gabapentin)
Contraindications: significant liver injury, concurrent
opioid use

Healthcare Disparities

48 responses: 29 residents, 5 HM, 2 hepatology, 1 pharmacy, 5 GI, 6
PCP

Other

In the past year…
12,851 orders
for methadone

Results and Intervention Planning
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